Mayne Pharma (MYX AU): This One's On You Jim As Court Dismisses Cosette's Appeal
Mayne is 61% adrift of Cosette's Offer price. Yet, Mayne doesn't scream "buy" here. 5x+ forward EV/EBITDA is ok. The market is expecting EBITDA to...
55 Views
Mayne Pharma (MYX AU): Synthetic Expert Call Transcript (26 Aug 2026)
Financial Architecture Inflation: Mayne Pharma's reported gross margins and EBITDA are structurally inflated by its balance sheet treatment of...
89 Views
Mayne Disagrees With Cosette On MAC
Mayne Pharma (MYX AU) has released its FY25 results. They appear decent. (more detail in "Discussions" at the bottom). And nothing apparent to...
1.7k Views
Mayne Pharma (MYX AU): Court Rules Cosette Cannot Walk
Mayne has been provided with a letter received from the Treasurer indicating that his “preliminary view is that the Proposed Acquisition would be...
963 Views
Primer: Mayne Pharma (MYX AU) - Oct 2025
Pending Acquisition by Cosette Pharma: Mayne Pharma's future is largely defined by a pending acquisition by Cosette Pharmaceuticals, which aims...
483 Views